Bio Essence Corporation (BIOE) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Bio Essence Corporation's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
2.54
Strong
WeakModerateStrong
P/B Ratio
-1.10
Equity Deficit
Earnings Yield
39.30%
Strong
WeakModerateStrong
Profitability Health
2025Return on Equity
-43.23%
Weak
WeakModerateStrong
Operating Margin
47.43%
Strong
WeakModerateStrong
Net Profit Margin
47.23%
Strong
WeakModerateStrong
Growth Indicators
2025Revenue Growth
485.78%
Strong
WeakModerateStrong
Net Income Growth
168.47%
Strong
WeakModerateStrong
EPS Growth
168.60%
Strong
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
0.17
Weak
WeakModerateStrong
Quick Ratio
0.17
Weak
WeakModerateStrong
Asset Turnover
4.49x
Strong
WeakModerateStrong
Inventory Turnover
-
No data
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
68.83%
Strong
WeakModerateStrong
EV / Free Cash Flow
2.45x
Strong
WeakModerateStrong
Net Debt / EBITDA
1.74x
Weak
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.997
Strong
WeakModerateStrong
Return on Invested Capital
-1.76%
Weak
WeakModerateStrong
Cash Conversion Cycle
-32.74 days
Strong
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for BIOE.
View Financial Statements